Let's talk medical research

Are you attending the 13th annual DPharm conference in Boston on September 20-23?

Today, Antidote is excited to announce our collaboration with Beyond Type 1 and JDRF to release the first-ever Spanish-language clinical trial search engine for type 1 diabetes (T1D). This groundbreaking version of Antidote Match™ empowers users to search for type 1 diabetes trials in their preferred language, marking a significant step to improve diversity, equity, and inclusion in diabetes ...

As part of our efforts to better understand patients and their motivations to participate in clinical trials, Antidote and SCORR Marketing partnered on a survey to gain a deeper understanding of how patients think about the medical research process. Survey participants were recruited by eight of Antidote’s partners, including the American Kidney Fund, Allergy & Asthma Network, Healthline, ...

With over 2 billion daily active users, Facebook has one of the widest reaches on the internet today — especially for those trying to reach patients who may be interested in participating in clinical trials. However, because of the broad audience, there is also a lot of competition for users’ attention. This means that many advertisers must go through costly trial and error before they find the ...

When recruiting for a clinical trial, conducting effective outreach is an important component. However, once the initial contact is made with patients, it’s just as important that they are guided through the enrollment process.

Rheumatoid arthritis, also known as RA, is a chronic, autoimmune disease that primarily impacts the joints. It impacts 1.5 million people in the United States, with women being three times more likely to develop the condition. While RA does not typically exhibit symptoms early on, it becomes more impactful as it progresses, causing pain, swelling, stiffness, and an eventual loss of joint ...

Finding the right participants is essential to successful medical research, but unfortunately, many studies are unable to reach their targeted enrollment numbers with ease. Recruiting enough participants is often cited as one of the biggest clinical trial recruitment challenges, and many studies must be delayed or canceled due to a lack of randomizations.

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It primarily affects young and middle-aged men, and 80% of patients with PSC also have inflammatory bowel disease (IBD).

Helping patients find out about clinical trials is one of the chief pillars of the work Antidote does, and one of the ways we do this is through our partners. By building a network of nonprofits and patient advocacy groups, we are able to reach patients where they are and help them find clinical trial opportunities that may be a good fit.

In the age of the internet, effective clinical trial digital advertising is imperative to finding the right participants for a research study. Being able to reach patients where they are using outreach material that resonates is vital — but it doesn’t happen without smart, data-driven strategies.